JP Morgan Downgrades Amneal Pharmaceuticals to Underweight

JP Morgan downgrades Amneal Pharmaceuticals (NYSE:AMRX) from Neutral to Underweight.

Benzinga · 11/12/2019 12:02

JP Morgan downgrades Amneal Pharmaceuticals (NYSE:AMRX) from Neutral to Underweight.